CA3046220A1

CA3046220A1 - Dmd reporter models containing humanized duschene muscular dystrophy mutations

Dmd reporter models containing humanized duschene muscular dystrophy mutations Download PDF

Info

Publication number: CA3046220A1
Authority: CA; Canada
Prior art keywords: exon; human; sequence; cell; composition
Prior art date: 2016-12-08
Legal status : Abandoned

Application number

CA3046220A

Other languages

English (en)

French (fr)

Inventor

Leonela AMOASII

Chengzu LONG

Rhonda Bassel-Duby

Eric Olson

Current Assignee

University of Texas System

Original Assignee

University of Texas System

Priority date

2016-12-08

Filing date

2017-12-08

Publication date

2018-06-14

2017-12-08 Application filed by University of Texas System filed Critical University of Texas System

2018-06-14 Publication of CA3046220A1 publication Critical patent/CA3046220A1/en

Status Abandoned legal-status Critical Current

Links

230000035772 mutation Effects 0.000 title abstract description 56
201000006938 muscular dystrophy Diseases 0.000 title description 9
108010069091 Dystrophin Proteins 0.000 claims abstract description 146
108091033409 CRISPR Proteins 0.000 claims abstract description 144
230000014509 gene expression Effects 0.000 claims abstract description 72
239000005089 Luciferase Substances 0.000 claims abstract description 63
238000010354 CRISPR gene editing Methods 0.000 claims abstract description 57
108060001084 Luciferase Proteins 0.000 claims abstract description 27
210000002027 skeletal muscle Anatomy 0.000 claims abstract description 19
210000004165 myocardium Anatomy 0.000 claims abstract description 8
210000004027 cell Anatomy 0.000 claims description 232
108020005004 Guide RNA Proteins 0.000 claims description 116
239000000203 mixture Substances 0.000 claims description 74
239000013598 vector Substances 0.000 claims description 74
238000000034 method Methods 0.000 claims description 67
238000012217 deletion Methods 0.000 claims description 43
230000037430 deletion Effects 0.000 claims description 43
210000000287 oocyte Anatomy 0.000 claims description 35
108090000765 processed proteins & peptides Proteins 0.000 claims description 33
108700008625 Reporter Genes Proteins 0.000 claims description 32
108091005804 Peptidases Proteins 0.000 claims description 28
239000004365 Protease Substances 0.000 claims description 28
230000008685 targeting Effects 0.000 claims description 28
102000004196 processed proteins & peptides Human genes 0.000 claims description 24
229920001184 polypeptide Polymers 0.000 claims description 22
239000013603 viral vector Substances 0.000 claims description 20
230000003612 virological effect Effects 0.000 claims description 20
108091026890 Coding region Proteins 0.000 claims description 19
238000011144 upstream manufacturing Methods 0.000 claims description 19
108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
125000003729 nucleotide group Chemical group 0.000 claims description 18
238000013518 transcription Methods 0.000 claims description 17
230000035897 transcription Effects 0.000 claims description 17
239000013607 AAV vector Substances 0.000 claims description 16
102000004420 Creatine Kinase Human genes 0.000 claims description 15
108010042126 Creatine kinase Proteins 0.000 claims description 15
108020004485 Nonsense Codon Proteins 0.000 claims description 14
238000013519 translation Methods 0.000 claims description 14
230000000694 effects Effects 0.000 claims description 13
239000013612 plasmid Substances 0.000 claims description 13
108020004705 Codon Proteins 0.000 claims description 12
230000037433 frameshift Effects 0.000 claims description 11
239000002502 liposome Substances 0.000 claims description 11
108020004999 messenger RNA Proteins 0.000 claims description 11
230000010076 replication Effects 0.000 claims description 11
230000001939 inductive effect Effects 0.000 claims description 10
241001529936 Murinae Species 0.000 claims description 9
230000002950 deficient Effects 0.000 claims description 9
108020005345 3' Untranslated Regions Proteins 0.000 claims description 8
210000005260 human cell Anatomy 0.000 claims description 8
239000000126 substance Substances 0.000 claims description 8
210000004962 mammalian cell Anatomy 0.000 claims description 7
241001655883 Adeno-associated virus - 1 Species 0.000 claims description 3
241000702423 Adeno-associated virus - 2 Species 0.000 claims description 3
241000202702 Adeno-associated virus - 3 Species 0.000 claims description 3
241000580270 Adeno-associated virus - 4 Species 0.000 claims description 3
241001634120 Adeno-associated virus - 5 Species 0.000 claims description 3
241000972680 Adeno-associated virus - 6 Species 0.000 claims description 3
241001164823 Adeno-associated virus - 7 Species 0.000 claims description 3
241001164825 Adeno-associated virus - 8 Species 0.000 claims description 3
241000649045 Adeno-associated virus 10 Species 0.000 claims description 3
241000649046 Adeno-associated virus 11 Species 0.000 claims description 3
239000002105 nanoparticle Substances 0.000 claims description 2
238000012216 screening Methods 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 12
102100024108 Dystrophin Human genes 0.000 claims 6
238000010443 CRISPR/Cpf1 gene editing Methods 0.000 claims 4
102000001039 Dystrophin Human genes 0.000 abstract description 82
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 abstract description 81
241000699670 Mus sp. Species 0.000 abstract description 51
238000001727 in vivo Methods 0.000 abstract description 23
238000010172 mouse model Methods 0.000 abstract description 20
230000001404 mediated effect Effects 0.000 abstract description 19
238000012360 testing method Methods 0.000 abstract description 19
238000010362 genome editing Methods 0.000 abstract description 17
238000004458 analytical method Methods 0.000 abstract description 13
210000004413 cardiac myocyte Anatomy 0.000 abstract description 7
230000000747 cardiac effect Effects 0.000 abstract description 4
210000002363 skeletal muscle cell Anatomy 0.000 abstract description 4
208000026350 Inborn Genetic disease Diseases 0.000 abstract description 2
208000016361 genetic disease Diseases 0.000 abstract description 2
238000011577 humanized mouse model Methods 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 description 125
108020004414 DNA Proteins 0.000 description 66
108010029485 Protein Isoforms Proteins 0.000 description 55
102000001708 Protein Isoforms Human genes 0.000 description 55
102000004169 proteins and genes Human genes 0.000 description 55
210000003205 muscle Anatomy 0.000 description 46
108700024394 Exon Proteins 0.000 description 37
241000699666 Mus <mouse, genus> Species 0.000 description 36
102000039446 nucleic acids Human genes 0.000 description 36
108020004707 nucleic acids Proteins 0.000 description 36
150000007523 nucleic acids Chemical class 0.000 description 36
241000701161 unidentified adenovirus Species 0.000 description 30
230000002068 genetic effect Effects 0.000 description 22
108091032973 (ribonucleotides)n+m Proteins 0.000 description 21
101150015424 dmd gene Proteins 0.000 description 19
238000000338 in vitro Methods 0.000 description 19
238000012546 transfer Methods 0.000 description 19
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 17
239000002773 nucleotide Substances 0.000 description 17
108091093088 Amplicon Proteins 0.000 description 15
241000700605 Viruses Species 0.000 description 15
239000002253 acid Substances 0.000 description 15
238000012163 sequencing technique Methods 0.000 description 15
108091079001 CRISPR RNA Proteins 0.000 description 14
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
238000002347 injection Methods 0.000 description 13
239000007924 injection Substances 0.000 description 13
241001465754 Metazoa Species 0.000 description 12
230000001580 bacterial effect Effects 0.000 description 12
238000003776 cleavage reaction Methods 0.000 description 12
239000003623 enhancer Substances 0.000 description 12
230000007017 scission Effects 0.000 description 12
239000000243 solution Substances 0.000 description 12
208000024891 symptom Diseases 0.000 description 12
108010040615 apo-dystrophin 1 Proteins 0.000 description 11
239000000047 product Substances 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
230000029918 bioluminescence Effects 0.000 description 10
238000005415 bioluminescence Methods 0.000 description 10
201000010099 disease Diseases 0.000 description 10
239000003814 drug Substances 0.000 description 10
210000004940 nucleus Anatomy 0.000 description 10
238000004806 packaging method and process Methods 0.000 description 10
108020003175 receptors Proteins 0.000 description 10
102000005962 receptors Human genes 0.000 description 10
241001430294 unidentified retrovirus Species 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
108020005067 RNA Splice Sites Proteins 0.000 description 9
210000004263 induced pluripotent stem cell Anatomy 0.000 description 9
238000003780 insertion Methods 0.000 description 9
230000037431 insertion Effects 0.000 description 9
150000003839 salts Chemical class 0.000 description 9
238000010453 CRISPR/Cas method Methods 0.000 description 8
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
238000013459 approach Methods 0.000 description 8
239000011575 calcium Substances 0.000 description 8
229910052791 calcium Inorganic materials 0.000 description 8
230000006870 function Effects 0.000 description 8
210000000663 muscle cell Anatomy 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
125000006850 spacer group Chemical group 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
244000309466 calf Species 0.000 description 7
239000013604 expression vector Substances 0.000 description 7
239000005090 green fluorescent protein Substances 0.000 description 7
230000010354 integration Effects 0.000 description 7
238000000520 microinjection Methods 0.000 description 7
108020003589 5' Untranslated Regions Proteins 0.000 description 6
208000032170 Congenital Abnormalities Diseases 0.000 description 6
102100031780 Endonuclease Human genes 0.000 description 6
108010042407 Endonucleases Proteins 0.000 description 6
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
101001053946 Homo sapiens Dystrophin Proteins 0.000 description 6
230000008901 benefit Effects 0.000 description 6
238000010367 cloning Methods 0.000 description 6
238000012937 correction Methods 0.000 description 6
230000007423 decrease Effects 0.000 description 6
229940079593 drug Drugs 0.000 description 6
210000002257 embryonic structure Anatomy 0.000 description 6
229940088598 enzyme Drugs 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
238000007918 intramuscular administration Methods 0.000 description 6
210000002414 leg Anatomy 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
230000008569 process Effects 0.000 description 6
230000000750 progressive effect Effects 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
241000894007 species Species 0.000 description 6
-1 (3-Actin Proteins 0.000 description 5
238000001712 DNA sequencing Methods 0.000 description 5
108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
241000282412 Homo Species 0.000 description 5
206010028289 Muscle atrophy Diseases 0.000 description 5
101800001494 Protease 2A Proteins 0.000 description 5
108091028113 Trans-activating crRNA Proteins 0.000 description 5
210000001766 X chromosome Anatomy 0.000 description 5
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
239000002585 base Substances 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
210000000170 cell membrane Anatomy 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
238000005520 cutting process Methods 0.000 description 5
239000006185 dispersion Substances 0.000 description 5
210000002443 helper t lymphocyte Anatomy 0.000 description 5
230000000977 initiatory effect Effects 0.000 description 5
238000001964 muscle biopsy Methods 0.000 description 5
210000001087 myotubule Anatomy 0.000 description 5
239000002245 particle Substances 0.000 description 5
230000008488 polyadenylation Effects 0.000 description 5
230000001177 retroviral effect Effects 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
230000009261 transgenic effect Effects 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
230000004543 DNA replication Effects 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
208000010428 Muscle Weakness Diseases 0.000 description 4
206010028372 Muscular weakness Diseases 0.000 description 4
101710163270 Nuclease Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
108020005202 Viral DNA Proteins 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
239000012736 aqueous medium Substances 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
210000002808 connective tissue Anatomy 0.000 description 4
208000006111 contracture Diseases 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
238000003205 genotyping method Methods 0.000 description 4
238000003384 imaging method Methods 0.000 description 4
238000003364 immunohistochemistry Methods 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
229940079322 interferon Drugs 0.000 description 4
238000007912 intraperitoneal administration Methods 0.000 description 4
239000003446 ligand Substances 0.000 description 4
239000002609 medium Substances 0.000 description 4
201000000585 muscular atrophy Diseases 0.000 description 4
210000000130 stem cell Anatomy 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
239000003981 vehicle Substances 0.000 description 4
238000001262 western blot Methods 0.000 description 4
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 3
208000031229 Cardiomyopathies Diseases 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
230000007018 DNA scission Effects 0.000 description 3
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 3
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 3
206010019280 Heart failures Diseases 0.000 description 3
241001135569 Human adenovirus 5 Species 0.000 description 3
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 3
108010059343 MM Form Creatine Kinase Proteins 0.000 description 3
102000003792 Metallothionein Human genes 0.000 description 3
108090000157 Metallothionein Proteins 0.000 description 3
101100443350 Mus musculus Dmd gene Proteins 0.000 description 3
208000029549 Muscle injury Diseases 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
102000003970 Vinculin Human genes 0.000 description 3
108090000384 Vinculin Proteins 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000006978 adaptation Effects 0.000 description 3
230000003321 amplification Effects 0.000 description 3
108010084541 asialoorosomucoid Proteins 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
239000001506 calcium phosphate Substances 0.000 description 3
229910000389 calcium phosphate Inorganic materials 0.000 description 3
235000011010 calcium phosphates Nutrition 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000006378 damage Effects 0.000 description 3
230000034994 death Effects 0.000 description 3
238000012350 deep sequencing Methods 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
235000013601 eggs Nutrition 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
230000001605 fetal effect Effects 0.000 description 3
239000012530 fluid Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
108700004026 gag Genes Proteins 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
102000057878 human DMD Human genes 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000004072 lung Anatomy 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
239000012528 membrane Substances 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
244000005700 microbiome Species 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
230000009437 off-target effect Effects 0.000 description 3
210000003101 oviduct Anatomy 0.000 description 3
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical group C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 3
102000040430 polynucleotide Human genes 0.000 description 3
108091033319 polynucleotide Proteins 0.000 description 3
239000002157 polynucleotide Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000002265 prevention Effects 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
230000000241 respiratory effect Effects 0.000 description 3
230000029058 respiratory gaseous exchange Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
238000003757 reverse transcription PCR Methods 0.000 description 3
206010039722 scoliosis Diseases 0.000 description 3
210000001057 smooth muscle myoblast Anatomy 0.000 description 3
239000002904 solvent Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
CJDRUOGAGYHKKD-XMTJACRCSA-N (+)-Ajmaline Natural products O[C@H]1[C@@H](CC)[C@@H]2[C@@H]3[C@H](O)[C@@]45[C@@H](N(C)c6c4cccc6)[C@@H](N1[C@H]3C5)C2 CJDRUOGAGYHKKD-XMTJACRCSA-N 0.000 description 2
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
206010000234 Abortion spontaneous Diseases 0.000 description 2
241000604451 Acidaminococcus Species 0.000 description 2
206010001258 Adenoviral infections Diseases 0.000 description 2
201000006935 Becker muscular dystrophy Diseases 0.000 description 2
108010040467 CRISPR-Associated Proteins Proteins 0.000 description 2
108090000565 Capsid Proteins Proteins 0.000 description 2
206010007559 Cardiac failure congestive Diseases 0.000 description 2
102100023321 Ceruloplasmin Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108060005980 Collagenase Proteins 0.000 description 2
102000029816 Collagenase Human genes 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
102100025682 Dystroglycan 1 Human genes 0.000 description 2
108010071885 Dystroglycans Proteins 0.000 description 2
239000012594 Earle’s Balanced Salt Solution Substances 0.000 description 2
241000214054 Equine rhinitis A virus Species 0.000 description 2
206010016654 Fibrosis Diseases 0.000 description 2
241000710198 Foot-and-mouth disease virus Species 0.000 description 2
241000589601 Francisella Species 0.000 description 2
241000589599 Francisella tularensis subsp. novicida Species 0.000 description 2
206010017577 Gait disturbance Diseases 0.000 description 2
201000000628 Gas Gangrene Diseases 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
102100037907 High mobility group protein B1 Human genes 0.000 description 2
101710168537 High mobility group protein B1 Proteins 0.000 description 2
102000002265 Human Growth Hormone Human genes 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
108091054437 MHC class I family Proteins 0.000 description 2
102000043131 MHC class II family Human genes 0.000 description 2
108091054438 MHC class II family Proteins 0.000 description 2
241000713333 Mouse mammary tumor virus Species 0.000 description 2
101100494762 Mus musculus Nedd9 gene Proteins 0.000 description 2
206010062575 Muscle contracture Diseases 0.000 description 2
208000029578 Muscle disease Diseases 0.000 description 2
102000001068 Neural Cell Adhesion Molecules Human genes 0.000 description 2
108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 2
206010033799 Paralysis Diseases 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
241001672814 Porcine teschovirus 1 Species 0.000 description 2
108010071690 Prealbumin Proteins 0.000 description 2
102000007584 Prealbumin Human genes 0.000 description 2
241000605861 Prevotella Species 0.000 description 2
102000014450 RNA Polymerase III Human genes 0.000 description 2
108010078067 RNA Polymerase III Proteins 0.000 description 2
230000006819 RNA synthesis Effects 0.000 description 2
238000011529 RT qPCR Methods 0.000 description 2
102000054727 Serum Amyloid A Human genes 0.000 description 2
108700028909 Serum Amyloid A Proteins 0.000 description 2
101000910035 Streptococcus pyogenes serotype M1 CRISPR-associated endonuclease Cas9/Csn1 Proteins 0.000 description 2
108700026226 TATA Box Proteins 0.000 description 2
206010068872 Toe walking Diseases 0.000 description 2
108700019146 Transgenes Proteins 0.000 description 2
108700005077 Viral Genes Proteins 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000009471 action Effects 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
101150063416 add gene Proteins 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
210000004504 adult stem cell Anatomy 0.000 description 2
238000010171 animal model Methods 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
230000006793 arrhythmia Effects 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
229940124748 beta 2 agonist Drugs 0.000 description 2
230000027455 binding Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000022131 cell cycle Effects 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000000576 coating method Methods 0.000 description 2
229960002424 collagenase Drugs 0.000 description 2
210000004292 cytoskeleton Anatomy 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000006735 deficit Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
108700004025 env Genes Proteins 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
108091006047 fluorescent proteins Proteins 0.000 description 2
102000034287 fluorescent proteins Human genes 0.000 description 2
230000004927 fusion Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
210000004602 germ cell Anatomy 0.000 description 2
108010017007 glucose-regulated proteins Proteins 0.000 description 2
230000012010 growth Effects 0.000 description 2
101150028578 grp78 gene Proteins 0.000 description 2
210000005003 heart tissue Anatomy 0.000 description 2
239000012145 high-salt buffer Substances 0.000 description 2
230000006872 improvement Effects 0.000 description 2
239000000411 inducer Substances 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000007928 intraperitoneal injection Substances 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
230000001788 irregular Effects 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
210000003127 knee Anatomy 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
210000003141 lower extremity Anatomy 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
208000015994 miscarriage Diseases 0.000 description 2
210000003470 mitochondria Anatomy 0.000 description 2
210000003097 mucus Anatomy 0.000 description 2
206010028320 muscle necrosis Diseases 0.000 description 2
210000002569 neuron Anatomy 0.000 description 2
230000037434 nonsense mutation Effects 0.000 description 2
230000008520 organization Effects 0.000 description 2
210000004197 pelvis Anatomy 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
239000002644 phorbol ester Substances 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
238000000554 physical therapy Methods 0.000 description 2
108700004029 pol Genes Proteins 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
230000002028 premature Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
208000026526 progressive weakness Diseases 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000002510 pyrogen Substances 0.000 description 2
239000003642 reactive oxygen metabolite Substances 0.000 description 2
230000010837 receptor-mediated endocytosis Effects 0.000 description 2
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
210000003019 respiratory muscle Anatomy 0.000 description 2
208000023504 respiratory system disease Diseases 0.000 description 2
210000000518 sarcolemma Anatomy 0.000 description 2
210000000329 smooth muscle myocyte Anatomy 0.000 description 2
208000000995 spontaneous abortion Diseases 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
230000035882 stress Effects 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
210000001364 upper extremity Anatomy 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
101800000504 3C-like protease Proteins 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241000649044 Adeno-associated virus 9 Species 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
241000203069 Archaea Species 0.000 description 1
206010003497 Asphyxia Diseases 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000711404 Avian avulavirus 1 Species 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
108091032955 Bacterial small RNA Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 1
101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 1
101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 1
241000197194 Bulla Species 0.000 description 1
241001260012 Bursa Species 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
241000283707 Capra Species 0.000 description 1
102100027473 Cartilage oligomeric matrix protein Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
101710163595 Chaperone protein DnaK Proteins 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
206010056370 Congestive cardiomyopathy Diseases 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
238000010442 DNA editing Methods 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
206010061619 Deformity Diseases 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
206010012559 Developmental delay Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
102100039328 Endoplasmin Human genes 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
241000713813 Gibbon ape leukemia virus Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
102100022662 Guanylyl cyclase C Human genes 0.000 description 1
101710198293 Guanylyl cyclase C Proteins 0.000 description 1
108010062347 HLA-DQ Antigens Proteins 0.000 description 1
108010067802 HLA-DR alpha-Chains Proteins 0.000 description 1
108050008753 HNH endonucleases Proteins 0.000 description 1
102000000310 HNH endonucleases Human genes 0.000 description 1
101150112743 HSPA5 gene Proteins 0.000 description 1
101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
101100443349 Homo sapiens DMD gene Proteins 0.000 description 1
101000701363 Homo sapiens Phospholipid-transporting ATPase IC Proteins 0.000 description 1
101000595198 Homo sapiens Podocalyxin Proteins 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
241000598171 Human adenovirus sp. Species 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
108010003272 Hyaluronate lyase Proteins 0.000 description 1
102000001974 Hyaluronidases Human genes 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
208000029084 Hyperlordosis Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010021133 Hypoventilation Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108700002232 Immediate-Early Genes Proteins 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102000000588 Interleukin-2 Human genes 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
241001112693 Lachnospiraceae Species 0.000 description 1
241000904817 Lachnospiraceae bacterium Species 0.000 description 1
101710128836 Large T antigen Proteins 0.000 description 1
208000020358 Learning disease Diseases 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
239000012097 Lipofectamine 2000 Substances 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
208000034819 Mobility Limitation Diseases 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
102100026925 Myosin regulatory light chain 2, ventricular/cardiac muscle isoform Human genes 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
206010028851 Necrosis Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
241001028048 Nicola Species 0.000 description 1
102000006570 Non-Histone Chromosomal Proteins Human genes 0.000 description 1
108010008964 Non-Histone Chromosomal Proteins Proteins 0.000 description 1
101800001775 Nuclear inclusion protein A Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
102100030448 Phospholipid-transporting ATPase IC Human genes 0.000 description 1
101800001016 Picornain 3C-like protease Proteins 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
241001505332 Polyomavirus sp. Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
101800000596 Probable picornain 3C-like protease Proteins 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
241000205156 Pyrococcus furiosus Species 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
108091030071 RNAI Proteins 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
101000868151 Rattus norvegicus Somatotropin Proteins 0.000 description 1
108700005079 Recessive Genes Proteins 0.000 description 1
102000052708 Recessive Genes Human genes 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241001068263 Replication competent viruses Species 0.000 description 1
102000009661 Repressor Proteins Human genes 0.000 description 1
108010034634 Repressor Proteins Proteins 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
101100111629 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR2 gene Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
108010032838 Sialoglycoproteins Proteins 0.000 description 1
102000007365 Sialoglycoproteins Human genes 0.000 description 1
102000008063 Small Heat-Shock Proteins Human genes 0.000 description 1
108010088928 Small Heat-Shock Proteins Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
241000193996 Streptococcus pyogenes Species 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
239000008051 TBE buffer Substances 0.000 description 1
241001420369 Thosea Species 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
102000011923 Thyrotropin Human genes 0.000 description 1
108010061174 Thyrotropin Proteins 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
101710195626 Transcriptional activator protein Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
101800005109 Triakontatetraneuropeptide Proteins 0.000 description 1
102000004903 Troponin Human genes 0.000 description 1
108090001027 Troponin Proteins 0.000 description 1
102000013394 Troponin I Human genes 0.000 description 1
108010065729 Troponin I Proteins 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
108010065472 Vimentin Proteins 0.000 description 1
102100035071 Vimentin Human genes 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
108700029631 X-Linked Genes Proteins 0.000 description 1
208000019291 X-linked disease Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
VRGWBRLULZUWAJ-XFFXIZSCSA-N [(2s)-2-[(1r,3z,5s,8z,12z,15s)-5,17-dihydroxy-4,8,12,15-tetramethyl-16-oxo-18-bicyclo[13.3.0]octadeca-3,8,12,17-tetraenyl]propyl] acetate Chemical compound C1\C=C(C)/CC\C=C(C)/CC[C@H](O)\C(C)=C/C[C@@H]2C([C@@H](COC(C)=O)C)=C(O)C(=O)[C@]21C VRGWBRLULZUWAJ-XFFXIZSCSA-N 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
210000001361 achilles tendon Anatomy 0.000 description 1
239000013543 active substance Substances 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000013019 agitation Methods 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
238000002669 amniocentesis Methods 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
238000003491 array Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
210000002469 basement membrane Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000003012 bilayer membrane Substances 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
208000002352 blister Diseases 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
238000009534 blood test Methods 0.000 description 1
230000037396 body weight Effects 0.000 description 1
230000014461 bone development Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
210000001217 buttock Anatomy 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000005779 cell damage Effects 0.000 description 1
208000037887 cell injury Diseases 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
210000001136 chorion Anatomy 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
230000001447 compensatory effect Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
238000009223 counseling Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
210000001771 cumulus cell Anatomy 0.000 description 1
WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
229960001145 deflazacort Drugs 0.000 description 1
FBHSPRKOSMHSIF-GRMWVWQJSA-N deflazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O FBHSPRKOSMHSIF-GRMWVWQJSA-N 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
210000000852 deltoid muscle Anatomy 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000005782 double-strand break Effects 0.000 description 1
230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
206010013932 dyslexia Diseases 0.000 description 1
238000002567 electromyography Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
208000002854 epidermolysis bullosa simplex superficialis Diseases 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
210000004700 fetal blood Anatomy 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
230000003176 fibrotic effect Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
VRGWBRLULZUWAJ-UHFFFAOYSA-N fusaproliferin Natural products C1C=C(C)CCC=C(C)CCC(O)C(C)=CCC2C(C(COC(C)=O)C)=C(O)C(=O)C21C VRGWBRLULZUWAJ-UHFFFAOYSA-N 0.000 description 1
101150098622 gag gene Proteins 0.000 description 1
230000005021 gait Effects 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
238000010363 gene targeting Methods 0.000 description 1
231100000722 genetic damage Toxicity 0.000 description 1
231100000025 genetic toxicology Toxicity 0.000 description 1
230000001738 genotoxic effect Effects 0.000 description 1
231100000734 genotoxic potential Toxicity 0.000 description 1
210000002816 gill Anatomy 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
230000003067 hemagglutinative effect Effects 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
210000001624 hip Anatomy 0.000 description 1
210000001320 hippocampus Anatomy 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
210000004090 human X chromosome Anatomy 0.000 description 1
229940084986 human chorionic gonadotropin Drugs 0.000 description 1
229960002773 hyaluronidase Drugs 0.000 description 1
235000011167 hydrochloric acid Nutrition 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000008076 immune mechanism Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
238000003365 immunocytochemistry Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
230000009191 jumping Effects 0.000 description 1
229960003299 ketamine Drugs 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
210000004717 laryngeal muscle Anatomy 0.000 description 1
201000003723 learning disability Diseases 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000002483 medication Methods 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000004065 mitochondrial dysfunction Effects 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
230000037230 mobility Effects 0.000 description 1
230000020654 modulation by virus of host translation Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
101150008049 mx gene Proteins 0.000 description 1
210000003098 myoblast Anatomy 0.000 description 1
108010065781 myosin light chain 2 Proteins 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 1
230000003188 neurobehavioral effect Effects 0.000 description 1
208000018360 neuromuscular disease Diseases 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
230000036542 oxidative stress Effects 0.000 description 1
238000002496 oximetry Methods 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001991 pathophysiological effect Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
230000037081 physical activity Effects 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
210000004991 placental stem cell Anatomy 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
230000001144 postural effect Effects 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
230000003334 potential effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000001566 pro-viral effect Effects 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
208000037821 progressive disease Diseases 0.000 description 1
229930185346 proliferin Natural products 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
230000009325 pulmonary function Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000037425 regulation of transcription Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004202 respiratory function Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000033764 rhythmic process Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
238000005070 sampling Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000004904 shortening Methods 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
208000019116 sleep disease Diseases 0.000 description 1
208000020685 sleep-wake disease Diseases 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
108091007196 stromelysin Proteins 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
230000009182 swimming Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
238000010863 targeted diagnosis Methods 0.000 description 1
238000002626 targeted therapy Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
239000005495 thyroid hormone Substances 0.000 description 1
229940036555 thyroid hormone Drugs 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000011830 transgenic mouse model Methods 0.000 description 1
YFDSDPIBEUFTMI-UHFFFAOYSA-N tribromoethanol Chemical compound OCC(Br)(Br)Br YFDSDPIBEUFTMI-UHFFFAOYSA-N 0.000 description 1
229950004616 tribromoethanol Drugs 0.000 description 1
230000010415 tropism Effects 0.000 description 1
NMEHNETUFHBYEG-IHKSMFQHSA-N tttn Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 NMEHNETUFHBYEG-IHKSMFQHSA-N 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
230000007497 verbal memory Effects 0.000 description 1
210000003501 vero cell Anatomy 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
210000005048 vimentin Anatomy 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000001018 virulence Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
229960001600 xylazine Drugs 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1